Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$82,823,934
+$18,074,223 QoQ
Shares Held
326,117
+23.1% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#338
of 4,676 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Elo Mutual Pension Insurance Co holds $364,830,999 across 10 Drug Manufacturers - General names. JNJ ranks #2 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
85,566 | $102,630,435 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
326,117 | $82,823,934 | |
| 3 | ABBV |
AbbVie Inc.
|
194,138 | $48,852,886 | |
| 4 | MRK |
Merck & Co., Inc.
|
292,589 | $37,597,686 | |
| 5 | AMGN |
Amgen Inc
|
78,004 | $28,246,808 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
195,699 | $24,724,611 | |
| 7 | PFE |
Pfizer Inc
|
747,091 | $17,989,951 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
289,019 | $16,653,274 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $82,823,934 | 326,117 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $64,749,711 | 264,890 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $57,468,980 | 277,695 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $55,749,489 | 300,666 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $42,699,429 | 279,538 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $46,764,889 | 281,988 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $31,770,121 | 219,680 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $37,067,659 | 228,728 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $31,676,087 | 216,722 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $34,794,997 | 219,957 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $32,952,077 | 210,234 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $31,387,051 | 201,522 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $35,392,810 | 213,828 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $32,357,955 | 208,761 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $35,953,927 | 203,532 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $32,285,490 | 197,634 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $36,788,769 | 207,249 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $36,092,357 | 203,647 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $33,855,608 | 197,905 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $29,591,483 | 183,229 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $30,276,411 | 183,783 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $31,213,680 | 189,922 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $29,459,490 | 187,187 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,072,260 | 13,919 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||